Drug Approvals, Upbeat Earnings Help Vertex Pharmaceuticals' Stock Jump 20% In A Month

Vertex Pharmaceuticals (NASDAQ: VRTX) is an American biopharmaceutical company mainly focused on developing and commercializing therapies for the treatment of cystic fibrosis. Vertex has seen its stock price rise 15% over the last month, driven in part by the U.S. Food and Drug Administration...